Screener
Bio-Rad Laboratories BIO Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Interest expense | 12.3 | 12.0 |
| Foreign currency exchange gains, net | (2.4) | (2.7) |
| (Gains) losses from change in fair market value of equity securities and loan receivable | 738.2 | (31.8) |
| Other income, net | (24.2) | (37.2) |
| Income (loss) before income taxes | (689.8) | 83.4 |
| (Provision for) benefit from income taxes | 162.7 | (19.4) |
| Net income (loss) | $(527.1) | $64.0 |
| Basic earnings (loss) per share: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's other income (expense)?
- Bio-Rad Laboratories (BIO) reported other income (expense) of $24.2M in Q1 2026.
- How has Bio-Rad Laboratories's other income (expense) changed year-over-year?
- Bio-Rad Laboratories's other income (expense) decreased by 34.9% year-over-year, from $37.2M to $24.2M.
- What is the long-term trend for Bio-Rad Laboratories's other income (expense)?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's other income (expense) has grown at a 35.5% compound annual growth rate (CAGR), from $26.78M to $90.3M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Bio-Rad Laboratories's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude